2018 September 12


September 12, 2018

IDWeek 2018

Preparing for Hurricane Florence and Potential ID Impacts

As the hurricane season reaches its peak, and Hurricane Florence brings threats of catastrophic weather events and flooding to the eastern United States, preparation and sustained responses will be essential to prevent and respond to public health and infectious disease impacts that pose risks in a storm’s aftermath.

Read More


Efforts to Delay Harmful E/M Payment Proposal Gain Traction on Capitol Hill

IDSA and HIVMA have been educating members of Congress on the devastating impact on patient care and the ID/HIV workforce of the CMS proposed policies to collapse outpatient evaluation and management (E/M) codes and dramatically cut reimbursement for the most complex visits.


Journal Club Icon

Journal Club

In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine. 
Reviews in this issue: Long-term Care Facility Residents: A Significant Source of Intra- and Inter-facility C. difficile Transmission; Patients Living with HIV and Chronic Pain Treated with Long-Term Opioid Therapy Had Lower Rates of Virologic Failure

Read More


Need to Prep for the ID Board Exam? Sign Up for the IDSA Practice Exam

IDSA, in cooperation with the National Board of Medical Examiners, has created a timed Practice Exam designed to prepare physicians for the ID Board Exam.

Read More

ID Tech

Join IDSA and CDC and Commit to Combatting AMR

On Sept. 25, the Centers for Disease Control and Prevention will launch a global year-long AMR Challenge, and has asked IDSA and our members and other organizations to commit to playing a part in combatting antimicrobial resistance.

Read More


IDSA Intensifies Efforts to Preserve Patient Access to In Vitro Diagnostics

The House Energy & Commerce Committee is considering the draft Diagnostic Accuracy and Innovation Act (DAIA), a bill that would initiate Food and Drug Administration (FDA) regulation of laboratory developed tests (LDTs).


Flag Stethoscope

Advocates in Action: IDSA Members Talk ID with Policy Makers

Members hosted congressional member and staff visits in the Bronx and New Jersey, offering insight into IDSA priorities including the urgent need for antibiotics research and development and the importance of federal funding for ID and HIV programs.


Global Health

Science Speaks: Efforts to Change HIV, TB Outcomes

IDSA’s Science Speaks blog covers TB treatment trials and medical issues facing sex workers with regard to access and services.



IDSA & ID in the News

On a daily basis, IDSA spokespersons interview with media organizations across the country, providing facts, perspectives and important public health information about infectious diseases to the public.



ICYMI: What’s Hot on MyIDSA

Keep up with the latest information on the MyIDSA community boards. 

Read More